World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
83
Citations
25191
World Ranking
989
National Ranking
451

Matthew B. Frieman publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Matthew B. Frieman sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 165 publications — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Matthew B. Frieman D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Matthew B. Frieman sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 83 D-Index — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Matthew B. Frieman is a researcher affiliated with the University of Maryland, Baltimore in the United States. Their work primarily focuses on the field of medicine, with significant contributions to subfields including infectious diseases, immunology, epidemiology, molecular biology, and animal science and zoology.

The main topics covered by Matthew B. Frieman's research include:

  • SARS-CoV-2 and COVID-19 research
  • COVID-19 clinical research studies
  • Animal virus infections studies
  • Interferon and immune responses
  • Respiratory viral infections research
  • Viral gastroenteritis research and epidemiology
  • SARS-CoV-2 detection and testing

Notable recent papers authored or co-authored by Frieman cover a range of topics related to COVID-19 and viral infections. Selected works include:

  • "Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail," 2020, Science
  • "Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine," 2020, New England Journal of Medicine
  • "Animal models for COVID-19," 2020, Nature
  • "Selective Naked-Eye Detection of SARS-CoV-2 Mediated by N Gene Targeted Antisense Oligonucleotide Capped Plasmonic Nanoparticles," 2020, ACS Nano
  • "SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice," 2021, Nature Communications

Frequent collaborators in Frieman's research include James Logue, Stuart Weston, Marisa E. McGrath, Carly Dillen, and Ralph S. Baric. These co-authors have multiple joint publications, indicating an active research network.

Regular publication venues for Frieman's work consist of:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • UNC Libraries
  • Nature Communications
  • Journal of Virology
  • Science Translational Medicine

Best Publications

  • Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail.

    Johanna Hansen;Alina Baum;Kristen E. Pascal;Vincenzo Russo

  • Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine.

    Cheryl Keech;Gary Albert;Iksung Cho;Andreana Robertson

  • Animal models for COVID-19.

    César Muñoz-Fontela;William E. Dowling;Simon G.P. Funnell;Pierre S. Gsell

  • Severe Acute Respiratory Syndrome Coronavirus Open Reading Frame (ORF) 3b, ORF 6, and Nucleocapsid Proteins Function as Interferon Antagonists

    Sarah A. Kopecky-Bromberg;Luis Martínez-Sobrido;Matthew Frieman;Ralph A. Baric

  • Selective Naked-Eye Detection of SARS-CoV-2 Mediated by N Gene Targeted Antisense Oligonucleotide Capped Plasmonic Nanoparticles.

    Parikshit Moitra;Maha Alafeef;Maha Alafeef;Maha Alafeef;Ketan Dighe;Matthew B. Frieman

  • Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.

    David E. Gordon;Joseph Hiatt;Mehdi Bouhaddou;Veronica V. Rezelj

  • Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection

    Julie Dyall;Christopher M. Coleman;Brit J. Hart;Thiagarajan Venkataraman

  • Severe Acute Respiratory Syndrome Coronavirus ORF6 Antagonizes STAT1 Function by Sequestering Nuclear Import Factors on the Rough Endoplasmic Reticulum/Golgi Membrane

    Matthew Frieman;Boyd Yount;Mark Heise;Sarah A. Kopecky-Bromberg

  • Bats and Coronaviruses.

    Arinjay Banerjee;Kirsten Kulcsar;Vikram Misra;Matthew Frieman

  • SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice.

    Jing Hui Tian;Nita Patel;Robert Haupt;Haixia Zhou

  • Antiviral Potential of ERK/MAPK and PI3K/AKT/mTOR Signaling Modulation for Middle East Respiratory Syndrome Coronavirus Infection as Identified by Temporal Kinome Analysis

    Jason Kindrachuk;Britini Ork;Brit J. Hart;Steven Mazur

  • A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics.

    Longlong Si;Haiqing Bai;Melissa Rodas;Wuji Cao

  • Severe Acute Respiratory Syndrome Coronavirus Papain-Like Protease Ubiquitin-Like Domain and Catalytic Domain Regulate Antagonism of IRF3 and NF-κB Signaling

    Matthew Frieman;Kiira M. Ratia;Robert E. Johnston;Andrew D. Mesecar

  • Genetic analysis of complex traits in the emerging Collaborative Cross

    David L. Aylor;William Valdar;Wendy Foulds-Mathes;Ryan J. Buus

  • Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection

    Kirsten A. Kulcsar;Christopher M. Coleman;Sarah E. Beck;Matthew B. Frieman

  • Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain.

    Marc G. Wathelet;Melissa Orr;Matthew B. Frieman;Ralph S. Baric

  • Evidence Supporting a Zoonotic Origin of Human Coronavirus Strain NL63

    Jeremy Huynh;Shimena Li;Boyd Yount;Alexander Smith

  • Purified coronavirus Spike protein nanoparticles induce coronavirus neutralizing antibodies in mice

    Christopher M. Coleman;Ye V. Liu;Haiyan Mu;Justin K. Taylor

  • Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice

    Boyd Yount;Rhonda S. Roberts;Amy C. Sims;Damon Deming

  • Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2.

    Saman Saadat;Zahra Rikhtegaran Tehrani;James Logue;Michelle Newman

  • Insights from nanomedicine into chloroquine efficacy against COVID-19.

    Tony Y. Hu;Matthew Frieman;Joy Wolfram

Frequent Co-Authors

Ralph S. Baric
Ralph S. Baric University of North Carolina at Chapel Hill
Mark T. Heise
Mark T. Heise University of North Carolina at Chapel Hill
Boyd Yount
Boyd Yount University of North Carolina at Chapel Hill
Lisa E. Hensley
Lisa E. Hensley National Institutes of Health
Peter B. Jahrling
Peter B. Jahrling National Institute of Allergy and Infectious Diseases
Donald E. Ingber
Donald E. Ingber Harvard University
Gale Smith
Gale Smith Novavax (United States)
Eric F. Donaldson
Eric F. Donaldson Center for Drug Evaluation and Research
Michael R. Holbrook
Michael R. Holbrook National Institutes of Health
Adolfo García-Sastre
Adolfo García-Sastre Icahn School of Medicine at Mount Sinai

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in studying microbiology in the USA, exploring complementary online degrees can broaden career opportunities. Programs like an online health information management degree programs cahiim accredited provide essential skills for managing healthcare data, which is increasingly important in biological research and clinical settings.

Medical billing and coding is another relevant field, offering quick certification pathways. Many students benefit from fast online medical billing and coding certification programs, which can lead to entry-level positions in healthcare administration—roles that frequently collaborate with microbiology labs and healthcare providers.

Beyond microbiology, there are several online healthcare degrees that pay well, such as nursing and public health, which align well with a background in biological sciences. These degrees offer both flexibility and strong return on investment, especially when pursued online.

Public health professionals play a vital role in disease control and prevention. For those wanting to expand into this area, numerous accredited online mph programs easy to get into can provide a smooth entry point into the public health sector, complementing microbiology expertise and opening doors to diverse career pathways.

Best Scientists Citing Matthew B. Frieman

Trending Scientists

Recently Published Articles